Welcome To

LifeSci Capital

A research-driven investment bank with a sole focus on the life sciences

A New Model for Equity Research and Investor Engagement

Our team is dedicated to high quality, expert inspired equity research that compels investors to listen, read, engage, and convert into shareholders

40

Companies

Under coverage with an average market cap of $470M

40

KOL events in 2021 & 2022

7 dinners and 33 live calls

46

IPOs & Follow Ons

Average deal size $135M

232

Meetings

Average of 10 meetings per NDR

A Differentiated Model Focused on Quality

We generate thoroughly researched and insightful "deep dive" analyses that provide value to investors

Expert Driven

Expert engagement is at the core of our process, enabling us to have informed views on complex topics

Investor Engagement

We engage broadly with investors through our equity research and expansive non-deal roadshow activities

Our Advantage

A distinct influence over investor engagement and behavior

We pair in-depth equity research with customized equity capital markets activities to raise the visibility of covered companies and educate investors on compelling opportunities

Thoughtful, Transparent Advice

We provide deep sector knowledge by focusing exclusively on the Life Sciences, paired with extensive capital markets advisory experience, and informed views with our open research platform

Equity Research

Our research analysts hold advanced scientific or medical degrees and produce research that is widely read by the most prominent life science institutional investors

Investment Banking

LifeSci Capital equips clients with independent advisory services and experienced counsel to assist in making fully informed capital markets decisions

Equity Capital Markets

We use our research and research related activities to actively engage the investment community, first with our research analysts and ultimately with our clients